IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Expert Review of Anticancer Therapy- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on May 27, 2022

Impact Score

3.12

h-Index

 72

Rank

 5220

SJR

 0.852

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title Expert Review of Anticancer Therapy
Abbreviation Expert Rev. Anticancer Ther.
Publication Type Journal
Subject Area, Categories, Scope Oncology (Q2); Pharmacology (medical) (Q2)
h-index 72
Overall Rank/Ranking 5220
SCImago Journal Rank (SJR) 0.852
Impact Score 3.12
Publisher Taylor and Francis Ltd.
Country United Kingdom
ISSN 14737140, 17448328




Aim and Scope


Expert Review of Anticancer Therapy (ISSN 1473-7140) provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches.

Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. All articles are subject to rigorous peer-review, and the journal makes an essential contribution to decision-making in cancer care.


About Expert Review of Anticancer Therapy


Expert Review of Anticancer Therapy is a journal covering the technologies/fields/categories related to Oncology (Q2); Pharmacology (medical) (Q2). It is published by Taylor and Francis Ltd.. The overall rank of Expert Review of Anticancer Therapy is 5220. According to SCImago Journal Rank (SJR), this journal is ranked 0.852. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 72. The best quartile for this journal is Q2.

The ISSN of Expert Review of Anticancer Therapy journal is 14737140, 17448328. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Expert Review of Anticancer Therapy is cited by a total of 1358 articles during the last 3 years (Preceding 2021).


Expert Review of Anticancer Therapy Impact Score 2021-2022


The impact score (IS) 2021 of Expert Review of Anticancer Therapy is 3.12, which is computed in 2022 as per its definition. Expert Review of Anticancer Therapy IS is decreased by a factor of 0.56 and approximate percentage change is -15.22% when compared to preceding year 2020, which shows a falling trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Expert Review of Anticancer Therapy Impact Score 2022 Prediction


IS 2021 of Expert Review of Anticancer Therapy is 3.12. If the same downward trend persists, impact score may fall in 2022 as well.


Impact Score Trend


Year wise Impact Score (IS) of Expert Review of Anticancer Therapy. Based on Scopus data.


Year Impact Score (IS)
2022/2023 Coming Soon
2021 3.12
2020 3.68
2019 3.13
2018 2.34
2017 2.06
2016 2.06
2015 2.03
2014 2.29

Expert Review of Anticancer Therapy h-index


  Table Setting

Expert Review of Anticancer Therapy has an h-index of 72. It means 72 articles of this journal have more than 72 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Expert Review of Anticancer Therapy ISSN


The ISSN of Expert Review of Anticancer Therapy is 14737140, 17448328. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Expert Review of Anticancer Therapy Rank and SCImago Journal Rank (SJR)


The overall rank of Expert Review of Anticancer Therapy is 5220. According to SCImago Journal Rank (SJR), this journal is ranked 0.852. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Expert Review of Anticancer Therapy Publisher


Table Setting

Expert Review of Anticancer Therapy is published by Taylor and Francis Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2001-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Expert Review of Anticancer Therapy is Expert Rev. Anticancer Ther.. This abbreviation ('Expert Rev. Anticancer Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Expert Review of Anticancer Therapy


If your research field is/are related to Oncology (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Lasers in Surgery and Medicine journal 6312 Wiley-Liss Inc. 117 3.19
Revue Belge d'Archeologie et d'Histoire de l'Art journal 25383 The Royal Academy of Archaeology of Belgium 1 0.00
Wenshan Review of Literature and Culture journal 24094 National Chengchi University 2 0.09
Dados journal 17974 Inst. Univ. de Pesquisas do Rio de Janeiro 28 0.54
Spektrum der Augenheilkunde journal 22818 Springer-Verlag Wien 10 0.05
Coronary Artery Disease journal 12193 Lippincott Williams and Wilkins Ltd. 64 1.16
Journal for Weavers, Spinners and Dyers journal 26682 Association of Guilds of Weavers, Spinners and Dyers 2 0.01
Journal of Dynamical and Control Systems journal 8967 Springer New York 35 1.67
International Sociology journal 8251 SAGE Publications Ltd 60 3.60
ELH - English Literary History journal 19819 Johns Hopkins University Press 22 0.26

Check complete list




Year wise Impact Score (IS) of Expert Review of Anticancer Therapy

Impact Score Table

Year Impact Score (IS)
2022/2023 Coming Soon
2021 3.12
2020 3.68
2019 3.13
2018 2.34
2017 2.06
2016 2.06
2015 2.03
2014 2.29



Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Lancet Oncology, The
Lancet Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

JAMA Oncology
American Medical Association | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Cancer Discovery
American Association for Cancer Research Inc. | United States

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Neurotherapeutics
Springer New York | United States

ACS Pharmacology and Translational Science
American Chemical Society | United States

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

Journal of acquired immune deficiency syndromes (1999)
Lippincott Williams and Wilkins Ltd. | United States

See All